BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Millennium Pharmaceuticals, Inc. (South San Francisco, California) 

256 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-244-6800-Main-650-244-6893-Investor Fax: 650-244-9208


SEARCH JOBS






Collaborations

CuraGen Corporation (Acquired by Celldex Therapeutics, Inc.)  Product Discovery and Pharmacogenomics





 Company News
SEC Sues Filmmaker for Insider Trading Ahead of Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM), Sepracor Acquisitions 9/24/2013 8:52:52 AM
Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) Announces $13 Million Equity Financing 6/13/2011 7:12:36 AM
Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) VELCADE Improved Outcomes in Multiple Myeloma Patients After Transplant in Nordic Myeloma Study 5/6/2011 9:15:47 AM
Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) Leadership in Proteasome Inhibition Highlighted in Relapsed/Refractory Multiple Myeloma At IMW Meeting 5/5/2011 10:22:01 AM
Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) Submits Two Supplemental NDAs to FDA for VELCADE 4/26/2011 8:52:43 AM
Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) and Sunesis Pharmaceuticals, Inc. (SNSS) Announce Collaboration for Kinase Inhibitors in Oncology; Sunesis Receives a $4 Million Payment 4/5/2011 7:08:06 AM
Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) Becomes First Licensed Customer for BioClinica, Inc.’s New Enterprise Demand Aggregator 3/30/2011 10:16:55 AM
Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) Selects OrgPlus to Deliver Accurate Workforce Insight 7/13/2010 3:33:31 PM
Seattle Genetics, Inc. (SGEN) and Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedotin (SGN-35) for Front-line Hodgkin Lymphoma 2/3/2010 10:14:32 AM
Seattle Genetics, Inc. (SGEN) Announces Antibody-Drug Conjugate Collaboration With Millennium: The Takeda Oncology Company 4/6/2009 7:23:44 AM
12345678910...